Prime Medicine, Inc. Common Stock (PRME) is a publicly traded Healthcare sector company. As of September 3, 2026, PRME trades at $3.57 with a market cap of $647.52M and a P/E ratio of -2.70. PRME moved +0.95% today. Year to date, PRME is +3.97%; over the trailing twelve months it is +9.88%. Its 52-week range spans $1.11 to $6.94. Analyst consensus is strong buy with an average price target of $7.71. Rallies surfaces PRME's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
8 analysts cover PRME: 0 strong buy, 7 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $7.71.
| Metric | Value |
|---|---|
| Price | $3.57 |
| Market Cap | $647.52M |
| P/E Ratio | -2.70 |
| EPS | $-1.35 |
| Dividend Yield | 0.80% |
| 52-Week High | $6.94 |
| 52-Week Low | $1.11 |
| Volume | 83.43K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.63M |
| Net Income | $-201.14M |
| Gross Margin | 0.00% |
8 analysts cover PRME: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.71.